Cargando…
Development of Prognostic Evaluation Model to Predict the Overall Survival and Early Recurrence of Hepatocellular Carcinoma
BACKGROUND: The aberrant expressions of lncRNAs have been frequently demonstrated to be closely associated with the prognosis of patients in many cancer types including hepatocellular carcinoma (HCC). Integration of these lncRNAs might provide accurate evaluation of HCC. Therefore, this study aims t...
Autores principales: | Zhong, Yue, Yang, Yong, He, Lei, Zhou, Yang, Cheng, Niangmei, Chen, Geng, Zhao, Bixing, Wang, Yingchao, Wang, Gaoxiong, Liu, Xiaolong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092946/ https://www.ncbi.nlm.nih.gov/pubmed/33954152 http://dx.doi.org/10.2147/JHC.S303330 |
Ejemplares similares
-
MT1G serves as a tumor suppressor in hepatocellular carcinoma by interacting with p53
por: Wang, Yingchao, et al.
Publicado: (2019) -
LncRNA TIALD contributes to hepatocellular carcinoma metastasis via inducing AURKA lysosomal degradation
por: Wang, Yingchao, et al.
Publicado: (2023) -
The serum proteomics tracking of hepatocellular carcinoma early recurrence following radical resection
por: Liu, Hongzhi, et al.
Publicado: (2019) -
Magnetically responsive nanoplatform targeting circRNA circ_0058051 inhibits hepatocellular carcinoma progression
por: You, Song, et al.
Publicado: (2022) -
Nomograms for Predicting Hepatocellular Carcinoma Recurrence and Overall Postoperative Patient Survival
por: Ma, Lidi, et al.
Publicado: (2022)